Previous 10 | Next 10 |
home / stock / cybr / cybr articles
CyberArk Software (NASDAQ:CYBR) has outperformed the market over the past 5 years by 13.39% on an annualized basis producing an average annual retu...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
U.S. stocks traded mixed, with the Dow Jones gaining around 20 points on Thursday. Shares of Arm Holdings plc (NASDAQ: ARM) shares rose sharply du...
SolarWinds Corp (NYSE:SWI) stock climbed after it reported a fourth-quarter FY23 revenue growth of 6% year-on-year to $198.14 million, beating...
U.S. stock futures suggest a subdued start for Wall Street on Thursday amidst anticipation of more earnings reports. The Dow may find support from&...
Tech earnings season starts in earnest next week, with the likes of Netflix, Inc. (NASDAQ:NFLX), Tesla, Inc. (NASDAQ:TSLA), Intel Corp. (NASDAQ:INT...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise ...
The recent cyberattack on the New York branch of the Industrial and Commercial Bank of China (OTC: IDCBY), causing disruptions in the U.S...
News, Short Squeeze, Breakout and More Instantly...
CyberArk Software Ltd. Company Name:
CYBR Stock Symbol:
NASDAQ Market:
CyberArk Software Ltd. Website:
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
2024-07-11 07:30:04 ET Barclays analyst issues OVERWEIGHT recommendation for CYBR on July 11, 2024 05:35AM ET. The previous analyst recommendation was Overweight. CYBR was trading at $271.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...